<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS RESTATED SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMBINED FINANCIAL STATEMENTS OF GENZYME CORPORATION'S GENERAL DIVISION FOR THE
YEAR ENDED DECEMBER 31, 1995 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
                             
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1995
<PERIOD-END>                               DEC-31-1995
<EXCHANGE-RATE>                                      1
<CASH>                                         103,631
<SECURITIES>                                   105,471
<RECEIVABLES>                                   94,954
<ALLOWANCES>                                     7,833
<INVENTORY>                                     52,281
<CURRENT-ASSETS>                               370,612
<PP&E>                                         391,287
<DEPRECIATION>                                  63,826
<TOTAL-ASSETS>                                 854,586
<CURRENT-LIABILITIES>                           62,576
<BONDS>                                        126,749
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           312
<OTHER-SE>                                     658,969
<TOTAL-LIABILITY-AND-EQUITY>                   854,586
<SALES>                                        351,603
<TOTAL-REVENUES>                               378,563
<CGS>                                          145,101
<TOTAL-COSTS>                                  317,539
<OTHER-EXPENSES>                                   112
<LOSS-PROVISION>                                 1,842
<INTEREST-EXPENSE>                               1,609
<INCOME-PRETAX>                                 65,329
<INCOME-TAX>                                    21,649
<INCOME-CONTINUING>                             43,680
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    43,680
<EPS-PRIMARY>                                     0.79<F1>
<EPS-DILUTED>                                     0.68<F1>
        
<FN>
<F1>NET INCOME PER SHARE ATTRIBUTABLE TO GENZYME GENERAL DIVISION COMMON STOCK
("GGD STOCK") FOR THE YEAR ENDED DECEMBER 31, 1995 HAS BEEN RESTATED TO CONFORM
TO SFAS 128. PRIMARY AND FULLY DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO GGD
STOCK COMPUTED UNDER THE PROVISIONS OF APB 15 WAS HISTORICALLY REPORTED AS
$0.73 AND $0.66 PER SHARE, RESPECTIVELY.
</FN>